CYP2D6 genotype and adverse drug reaction in the ICU

被引：0
|
作者：
Stamer, UM [1 ]
Bayerer, B [1 ]
Hoeft, A [1 ]
Stüber, F [1 ]
机构：
[1] Univ Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany
来源：
INTENSIVE CARE MEDICINE | 2003年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
34
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [41] COADMINISTRATION OF FLUVOXAMINE AND TOLPERISONE IN RELATION TO CYP2D6 GENOTYPE
    Kim, Y. H.
    Kim, S. H.
    Byeon, J. Y.
    Lee, H. J.
    Lee, Y.
    Lee, Y. J.
    Lee, S. Y.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E54 - E54
  • [42] Psychiatric Disorder or Adverse Drug Reaction? - How CYP2D6 Metabolizing Activity Can Result in Dextromethorphan Intoxication
    Ziesenitz, Victoria C.
    van den Anker, Johannes N.
    KLINISCHE PADIATRIE, 2019, 231 (01): : 46 - 48
  • [43] Catalytic in vivo function of CYP2D6 in relation to the genotype
    Griese, EU
    Gaedigk, A
    Morike
    Mikus, G
    Zanger, U
    Eichelbaum, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 458 - 458
  • [44] CYP2D6 genotype and optimization of breast cancer treatment
    Bandres, F.
    Chicharro, L. M.
    Tejerina, A.
    del Saz, M.
    Fernaacutendez-Santander, A.
    EJC SUPPLEMENTS, 2010, 8 (03): : 179 - 179
  • [45] Impact of CYP2D6 genotype on postoperative tramadol analgesia
    Stamer, UM
    Lehnen, K
    Höthker, F
    Bayerer, B
    Wolf, S
    Hoeft, A
    Stuber, F
    PAIN, 2003, 105 (1-2) : 231 - 238
  • [46] Effect of the CYP2D6*10 Genotype on Tolterodine Pharmacokinetics
    Oishi, Masayo
    Chiba, Koji
    Malhotra, Bimal
    Suwa, Toshio
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (09) : 1456 - 1463
  • [47] CYP2D6 genotype and phenotype relationship in South Indians
    Naveen, A. T.
    Prasanna, T.
    Farzana, B. L.
    Rajan, S.
    Adithan, C.
    JOURNAL OF POSTGRADUATE MEDICINE, 2006, 52 (04) : 253 - 256
  • [48] Genotype and allele frequency of CYP2D6 in Tamilian population
    Adithan, C
    Gerard, N
    Naveen, AT
    Koumaravelou, K
    Shashindran, CH
    Krishnamoorthy, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (07) : 517 - 520
  • [49] CYP2D6 genotype and smoking behaviour in cigarette smokers
    Boustead, C
    Taber, H
    Idle, JR
    Cholerton, S
    PHARMACOGENETICS, 1997, 7 (05): : 411 - 414
  • [50] Impact of the CYP2D6 utrarapid metabolizer genotype on mirtazapine pharmacokinetics and adverse events in healthy volunteers
    Kirchheiner, J
    Henckel, HB
    Meineke, I
    Roots, I
    Brockmöller, A
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (06) : 647 - 652
12345